Efficacy and Safety of Everolimus with Reduced Tacrolimus in Living-Donor Liver Transplant (LDLT) Recipients with Hepatocellular Carcinoma: Subgroup Analysis from the H2307 Study

被引：0
|
作者：
Jeng, L. -B. [1 ]
Lee, S. -G. [2 ]
Lee, W. -C. [3 ]
Suh, K. -S. [4 ]
Joo, D. J. [5 ]
Joh, J. [6 ]
Kaido, T. [7 ]
Lopez, P. [8 ]
Kochuparampil, J. [8 ]
Kaneko, S. [9 ]
Levy, G. [10 ]
机构：
[1] China Med Univ Hosp, Taichung, Taiwan
[2] Asan Med Ctr, Seoul, South Korea
[3] Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Seoul Natl Univ Hosp, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea
[6] Samsung Med Ctr, Seoul, South Korea
[7] Kyoto Univ Hosp, Kyoto, Japan
[8] Novartis Pharma AG, Basel, Switzerland
[9] Novartis Pharma KK, Tokyo, Japan
[10] Univ Toronto, Toronto, ON, Canada
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LB P-19
引用
收藏
页码：375 / 376
页数：2
相关论文
共 50 条
  • [21] Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation: 24-month results from the H2307 study
    Suh, Kyung Suk
    Jeng, Long-Bin
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Lee, Sung Gyu
    Grant, David
    Yoshizumi, Tomoharu
    El Meteini, Mahmoud
    Meier, Matthias
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2018, 102 : S21 - S22
  • [22] FIVE YEAR HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS PLUS REDUCED TACROLIMUS VS STANDARD TACROLIMUS AFTER LIVING-DONOR LIVER TRANSPLANTATION
    Sapisochin, Gonzalo
    Bin Jeng, Long
    Hata, Koichiro
    Lee, Wei Chen
    Joh, Jae-Won
    Joo, Dong Jin
    Soin, Arvinder Singh
    Veldandi, Uday Kiran
    Kaneko, Shuhei
    Jhala, Kanan
    Meier, Matthias
    Leclair, Denise
    Sunkara, Gangadhar
    TRANSPLANT INTERNATIONAL, 2021, 34 : 211 - 211
  • [23] Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients
    Azam, Fahad
    Khan, Moosa
    Bhatti, Abu Bakar Hafeez
    Dar, Faisal Saud
    Ahmad, Arsalan
    Javed, Nismat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (11): : 1048 - 1052
  • [24] Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients
    Fukudo, Masahide
    Yano, Ikuko
    Masuda, Satohiro
    Goto, Maki
    Uesugi, Miwa
    Katsura, Toshiya
    Ogura, Yasuhiro
    Oike, Fumitaka
    Takada, Yasutsugu
    Egawa, Hiroto
    Uemoto, Shinji
    Inui, Ken-ichi
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (04) : 331 - 345
  • [25] Effect of Everolimus with Reduced Tacrolimus on Renal Function after Living-Donor Liver Transplantation (LDLT): 1-Year Results from a Randomized International Study
    Lee, Gyu S.
    Jeng, L. -B.
    Soin, A. S.
    Suh, K. -S.
    Joo, Jin D.
    Lee, W. C.
    Inomata, Y.
    Lopez, P.
    Kochuparampil, J.
    Sips, C.
    Kaneko, S.
    Levy, G.
    TRANSPLANTATION, 2017, 101 (05) : 364 - 365
  • [26] 24-MONTH RESULTS FROM THE H2307 PIVOTAL STUDY: MTOR INHIBITION WITH EVEROLIMUS IN DE NOVO LIVING DONOR LIVER TRANSPLANTATION
    Braun, F.
    Meier, M.
    Sips, C.
    Kroeger, I.
    Settmacher, U.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 17 - 17
  • [27] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [28] EVEROLIMUS WITH REDUCED TACROLIMUS MAINTAINS EFFICACY FOLLOWING LIVING-DONOR LIVER TRANSPLANTATION (LDLT): 12-MONTH RESULTS FROM AN INTERNATIONAL RANDOMIZED TRIAL (NCT01888432)
    Braun, F.
    Settmacher, U.
    Lopez, P. M.
    Kochuparampil, J.
    Lieb, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 26 - 26
  • [29] Everolimus with Reduced Tacrolimus (EVR/rTAC) Maintains Efficacy Following Living Donor Liver Transplantation (LDLT): An International Randomized Trial
    Jeng, L. -B.
    Lee, Gyu S.
    Soin, A. S.
    Lee, W. -C.
    Yoshizumi, T.
    Lopez, P.
    Kochuparampil, J.
    Sips, C.
    Kaneko, S.
    Grant, D.
    TRANSPLANTATION, 2017, 101 (05) : 376 - 377
  • [30] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: A POST HOC SUBGROUP ANALYSIS OF ZEUS
    Lehner, F.
    Budde, K.
    Wuethrich, R. P.
    Witzke, O.
    Zeier, M.
    Hauser, I. A.
    Wolters, H. H.
    Suwelack, B.
    Heller, K.
    Reinke, P.
    Arns, W.
    Stahl, R.
    Muehlfeld, A.
    Eisenberger, U.
    Baeumer, D.
    Porstner, M.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 24 - 24
12345